Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
enVVeno Medical Corporation NVNO
$4.62
-$0.11 (-2.33%)
На 18:05, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
39024640.00000000
-
week52high
7.93
-
week52low
3.35
-
Revenue
0
-
P/E TTM
-2
-
Beta
1.24685000
-
EPS
-2.08000000
-
Last Dividend
0.00000000
-
Next Earnings Date
28 апр 2023 г. в 18:00
Описание компании
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Shrivastava Sanjay | A | 8403 | 8403 | 30 ноя 2022 г. |
| Jenusaitis Matthew | A | 8403 | 8403 | 30 ноя 2022 г. |
| Gray Robert | A | 8403 | 8403 | 30 ноя 2022 г. |
| Duhay Francis | A | 8403 | 8403 | 30 ноя 2022 г. |
| Jenusaitis Matthew | D | 0 | 1041 | 13 сент 2022 г. |
| Jenusaitis Matthew | A | 6925 | 1041 | 13 сент 2022 г. |
| Gray Robert | D | 0 | 1041 | 13 сент 2022 г. |
| Gray Robert | A | 7655 | 1041 | 13 сент 2022 г. |
| Duhay Francis | A | 20911 | 7751 | 16 авг 2022 г. |
| Shrivastava Sanjay | A | 3888 | 1000 | 30 июн 2022 г. |
Свежие комментарии
Свежие комментарии